Personalized therapies for diabetes, while showing promise in international studies, is met with healthy skepticism from ...
In a 14-month follow-up, Sana Biotechnology has found that its investigational allogeneic cell therapy continued to produce insulin in one patient with Type 1 diabetes, with no safety concerns ...
Diabetes develops when the body fails to manage its blood glucose levels. One form of diabetes causes the body to not produce insulin at all. Called Type 1 diabetes, or T1D, this autoimmune disease ...
Most of the insulinmedication that people use today is made from bacteria that have been genetically modified to produce insulin that is identical to the kind made in the human pancreas, according to ...
California Gov. Gavin Newsom announced on July 7 that his state would begin producing affordable insulin to help fight the high prices of this essential medication. The governor approved a budget ...
Stay up-to-date with free briefings on topics that matter to all Californians. Subscribe to CalMatters today for nonprofit news in your inbox. Gov. Gavin Newsom’s ambitious plan to produce a cheap, ...
Pharmaceutical companies layer on patents for drug delivery devices to maintain market exclusivity, according to a new study.
Gov. Gavin Newsom's ambitious plan to produce a cheap, generic insulin for the 3.2 million Californians with diabetes is behind the schedule he announced and unlikely to make it to market for several ...